Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat and IQ domain-containing protein 4 (LRRIQ4)
- Target
- LRRIQ4
- Molecular classification
- Other (Leucine-rich repeat protein; not in major druggable classes such as receptor, enzyme, transporter, or transcription factor)
01
Overview
Leucine-rich repeat and IQ domain-containing protein 4 (LRRIQ4), also known as LRRC64, is a human protein characterized by leucine-rich repeat motifs and an IQ calmodulin-binding domain[2][3]. It is predicted to be involved in intracellular signal transduction processes[3]. LRRIQ4 is part of a broader family of proteins with potential roles in the organization of signaling cascades, although its precise biological functions, molecular mechanisms, and roles in human disease are largely uncharacterized. There is currently no evidence that it serves as a validated therapeutic target, nor are there any known drugs or safety concerns associated with it based on available data[2][3].
- Other names
- Leucine rich repeats and IQ motif containing 4LRRC64Leucine-rich repeat-containing protein 64LRRC64 (redundant, but appears in databases)leucine rich repeat containing 64
02
Biological functions
Predicted role in intracellular signal transduction[3]
03
Disease associations
Other (No direct association with cancer, inflammation, or major disease areas established)
Beyond the preview
Go deeper on Leucine-rich repeat and IQ domain-containing protein 4 (LRRIQ4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leucine-rich repeat and IQ domain-containing protein 4 (LRRIQ4).